Chapters: 00:09 Intro, Rainy Day Banter & Q&A Format Explained 03:10 Why Different Personalities Make the Podcast Work 08:30 Stalled Fat Loss on GLPs & When to Switch Compounds 17:20 Bodyweight Training, Muscle Loss & Metabolism 22:40 Reta Stacks for Fat Loss Without Losing Muscle 31:00 Fasting, Food Timing & Peptide Use 38:20 Vetting Peptide Companies, COAs & Pricing Reality 48:40 TRT, Libido Issues & Estrogen Troubleshooting 57:10 CJC-1295 With vs Without DAC (First-Time Use) 1:00:10 Best Fat Loss Stacks to Run With Reta 1:09:45 SS-31, Mitochondria & Cardiovascular Support 1:11:10 When Surgery Beats Peptides for Healing 1:12:15 Podcast Growth, Future Plans & Outro We cover: Semax & Selank Longevity: BDNF, neuroplasticity, cycling vs continuous use, performance timing, and anxiety dosing strategies Ex-Powerlifter Recomp Plan: TRT + RETA setup, AOD, SLU-PP-332, 5-Amino-1MQ, GH for muscle retention, and how to train heavy for fat loss Training for Body Recomposition: Short rest periods, compound lifts, fasting integration, and hitting muscles twice per week for metabolic output Low-Dose RETA for Women: When to titrate up, why lowest effective dose matters, preserving muscle with Tesa-IPA, and where KPV fits RETA Reality Check: Appetite control vs starvation, habit change, food quality, and why its not a magic shot Thyroid Cancer Warning Explained: Rodent data vs human risk, MEN2 history, quality-of-life decision making, and doctor conversations that matter What to Stack with RETA: Fat-loss stacks vs mitochondria, anti-aging protocols, NAD timing, and GH for 40+ optimization Long-Term Low-Dose RETA: Metabolic health benefits, desensitization myths, titrating down vs coming off, and maintenance strategy Endurance Athletes & Fueling Issues: When RETA suppresses calories too much, MK-677/IPA for appetite, GH timing, and recovery support Peptide Safety & Contamination: China raws vs U.S
The Importance of Bioavailability Bioavailability refers to the proportion of a nutrient that enters the circulation when introduced into the body and is so able to have an active effect
Did the FDA Update Warnings for GLP-1 Medications
PMCID: PMC8074239
I want to make sure that we circle back to this, when it comes to the peptides, it seems that one of your approaches, if I may, is to raise the tide so that the boat can get out to sea
established patients can continue follow-up visits by Florida telehealth
.png.jpg)
